Search | WHO COVID-19 Research Database

Safe and informed prescribing of psychotropic medication during the COVID-19 pandemic.

Luykx, Jurjen J; van Veen, Sisco M P; Risselada, Arne; Naarding, Paul; Tijdink, Joeri K; Vinkers, Christiaan H.

Br J Psychiatry ; 217(3): 471-474, 2020 09.

Article in English | MEDLINE | ID: covidwho-154518

ABSTRACT

Treatment with psychotropic medication may sometimes be jeopardised because of the COVID-19 pandemic. One underlying reason is the lack of COVID-19-specific psychopharmacology guidelines. Here, we discuss five considerations arising from our clinical experience and pharmacological background knowledge to enable safe and well-informed psychopharmacotherapy during the COVID-19 pandemic.

Subject(s)

Anxiety , Coronavirus Infections , Mental Disorders , Pandemics , Pneumonia, Viral , Practice Patterns, Physicians'/standards , Psychotherapy , Psychotropic Drugs/therapeutic use , Anxiety/etiology , Anxiety/therapy , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/psychology , Humans , Inappropriate Prescribing/prevention & control , Medication Therapy Management/standards , Mental Disorders/epidemiology , Mental Disorders/therapy , Mental Health Services/trends , Netherlands/epidemiology , Patient Selection , Pneumonia, Viral/epidemiology , Pneumonia, Viral/psychology , Psychotherapy/methods , Psychotherapy/trends , SARS-CoV-2 , Telemedicine/methods

ABSTRACT

Subject(s)

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL